Answers are grounded in this paper and cite their sources.
There is little use of the residual yeast from brewing production. In this sense, the autolysis process of these yeasts will allow obtaining important components (polysaccharides, triglycerides, among others), with a future vision in the creation of food supplements, medicines and energy drinks. It is proposed as an objective to develop the lysis process, the liberation or obtaining of beta-glucans from S. cerevisiae yeast. A strain of Saccharomyces cerevisiae var. Bayanus cervecera was used and grown in a modified complex medium for yeast growth (YPD). Incubation was carried out in a shaker at 30°C at 150 rpm for 24 hours, culminating this growth phase, it was centrifuged at 1500 rpm for 20 minutes, in order to separate the solid and liquid parts of the yeast. The yeast lysis was performed using distilled water and 95% alcohol as experimental treatments in (A1, B1) 10, (A2, B2) 20 and (A3, B3) 30 minutes. The results of the solid part of each treatment were obtained, reading the absorbance level of the supernatant against distilled water at 540 nm. Applying the equation, the amount of beta-glucans was obtained, in treatments 1A and 4B at times of 10 and 20 minutes respectively, values of 0.49 g and 1.50 g. In this process the beta-glucans and other components of the yeast were released.
No takes yet. Share an insight, caveat, or question.
Rivera et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: